Although the randomized trials investigating the effect of myoinositol supplementation on the risk of gestational diabetes mellitus gave the encouraging effects in improving insulin resistance, multicenter studies on larger populations, comparing myoinositol with placebo, diet and exercise, and pharmacological interferences, and in double-blind randomized controlled trials are needed to determine the routine use of myoinositol. Here, INS is linked to gestational diabetes.